Email not displaying correctly? View it in your browser.
November 2016

Patient Care

Aggressive treatment proves successful for patients with pancreatic cancer
A new protocol that offers chemotherapy using FOLFIRINOX followed with radiation, marathon surgeries rarely tried in conventional treatment, and more FOLFIRINOX, has proved successful among patients with pancreatic cancer who previously would have been considered inoperable.

Multidisciplinary teams are crucial in rectal cancer care
Despite improvements in preoperative tumor staging and outcomes, evaluation and management of locally advanced rectal cancer presents ongoing challenges for physicians and patients, highlighting the need for multidisciplinary teams.


Radiation therapy plus PCV prolongs progression-free survival for patients with glioma
Study participants with glioma who received radiation therapy plus a chemotherapy regimen that included procarbazine, lomustine and vincristine (PCV) experienced a longer progression-free survival and overall survival than did participants who received radiation therapy alone.

BubR1 mutations prevent cancer in mouse models
Researchers examining mutations of BubR1 to determine how changes to each component of the protein affect the quality control checkpoints within cells, ensuring they divide properly, found two mutant proteins that were able to prevent cancer in the mouse models.

Toll-like receptor agonists trick the immune system into attacking cancer cells
A drug combination designed to enhance the immune system's ability to target and attack cancer cells has shown a pronounced therapeutic effect against aggressive forms of breast (4T1) and pancreatic (Panc02) cancers in mice.

Checkpoint inhibitor shows promise for patients with melanoma
Cancer cells often co-opt immune checkpoints — off-switches hardwired into the immune system to keep it from harming normal tissues and cells. Molecular markers that can track a patient's immune response to checkpoint-inhibitor therapies may expand applications to cancers other than melanoma.

See all Cancer Clinical Trials at Mayo Clinic

Back to Top


Mayo Clinic Radiation Oncology: Current Practice and Future Direction 2017
Jan. 9-13, 2017, in Maui, Hawaii
Topics include stereotactic ablative radiotherapy and head and neck, gynecologic, and gastrointestinal cancers. The course addresses advances such as proton therapy, imaging and new chemotherapies, as well as their integration into clinical practice.

Clinical and Multidisciplinary Hematology and Oncology: The 14th Annual Review 2017
Jan. 27-29, 2017, in Scottsdale, Ariz.
Focus includes new disease classifications and management strategies for key hematologic diseases (dysproteinemias, acute and chronic leukemias, and lymphomas), key solid tumors (breast, thoracic, gastrointestinal and genitourinary) and overlap topics of supportive, ancillary and diagnostic care.

Mayo Clinic Update in Urology 2017

Feb. 20-24, 2017, in Paradise Island, Bahamas
This course explores current modalities for risk stratification of patients with newly diagnosed prostate cancer, image-guided focal prostate therapy, robotic versus open surgery for prostatectomy and optimal approaches for high-grade prostate cancer.

See all Hematology and Oncology Continuous Professional Development courses

Consults & Referrals

Connect With Us

Facebook iconTwitter iconYoutube icon

Receive real-time news and thought-leading insight

Back to Top

Mayo Clinic
13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First St. SW
Rochester, MN 55905